Summary. Cytomegalovirus (CMV) is a source of major complications in immunosuppressed individuals, and endothelial involvement in CMV infection is well documented. Traditionally the virus has been propagated in fibroblasts, however this process may alter CMV's characteristics, thereby limiting the fibroblast model's utility as a research tool. In our efforts to develop a more accurate in vitro model of CMV/endothelial cell interaction, we have propagated a recent isolate (CMV VHL) through multiple passages in human umbilical vein endothelial cells (HUVE) and, collaterally in neonatal human dermal fibroblasts (NHDF). Infection of HUVE inoculated with either sub-strain of the virus was confirmed by CMV-specific in situ hybridization and by immunocytochemical staining for CMV antigens. Whereas infection of HUVE by substrain VHL/E (endothelial-raised) was accompanied by dramatic cytopathology resembling that observed clinically, the endothelial cytopathic potential of VHL/ F (fibroblast-raised) was lost by its 20th passage in NHDF. Similarly, the ability of VHL/F to initiate sustained productive infection in HUVE was severely attenuated; plaque assay of culture supernatants and infected cell fractions, as well as virus-specific DNA polymerase assay of cell lysates, demonstrated progressive viral reproductive activity in VHL/E-inoculated HUVE, whereas VHL/ F reproduction was barely detectable. Since properties of VHL/F bear strong resemblance to those of the fibroblast-raised AD 169, these studies suggest that while the fibroblast adaption process commonly employed in the propagation of CMV restricts the host range of the virus and attenuates its spectrum of cytopathic potential, endothelial-based propagation preserves the natural endothelial cytopathogenicity of the original isolate. 
Introduction
Cytomegalovirus (CMV) has received increasing attention in recent years as a prominent cause of morbidity and mortality among the immunosuppressed population [33] . Although the potential consequences of CMV infection in the immunocompromised host have been known for some time [24] , the magnitude of the problem has increased significantly with the growth in numbers of immunosuppressed individuals that has occurred in the last decade [28, 43, 46, 51, 60] . The impaired cellular immunity induced by immunosuppressive therapy has put organ transplant recipients at considerable risk of developing serious, often life-threatening CMV-associated complications [2, 4, 12, 14, 21, 24, 42, 52] . In addition, the loss of immune system integrity that occurs in the acquired immune deficiency syndrome leaves AIDS patients particularly vulnerable to frequently fatal disseminated infection with this virus [22, 25, 28, 32] .
Pulmonary infection remains most common [39] , and has been associated with interstitial pneumonia [2, 32, 46] . However, evidence for CMV infection in the immunocompromised host has been found in nearly every organ of the body [39] . Diffuse mucosal ulceration has been associated with CMV infections of the gastro-intestinal tract [12, 60] . CMV retinitis is another common complication, often progressing to a vision-threatening stage [1] . Although somewhat controversial, post-transplantation renal glomerulopathy may also be related to CMV infection [23, 47] . CMV hepatitis has been reported in liver transplant recipients [6, 42] , at times accompanied by vanishing bile-duct syndrome [40-1. Recently, an etiologic role has been proposed for CMV in the accelerated development of atherosclerosis within cardiac grafts [20] . Indeed several earlier studies have implicated CMV (and other herpesviruses) as a contributing factor in the atherogenic process [11, . In addition to the above examples, CMV has been postulated to play a role in atlograft reiection [3] .
Despite its significant health impact, the pathogenesis of CMV disease is poorly understood. The modes of transmission of the virus, as well as its routes of dissemination, are not entirely clear. Its potential to establish latency is strongly implicated [31] , however the latent state remains undefined [33] . Specific sites of latency, as well as mechanisms of reactivation also remain elusive [33] . In response to these uncertainties evidence continues to accumulate implicating the endothelial cell as a common target of infection regardless of the organ involved [1, 9, 12, 19, 22, 25, 34, 39, 49, 62, 65] . These findings suggest that this cell type may be an important mediator in the pathogenesis of human CMV disease [36] .
Clearly an in vitro model would be useful; however, results of the several published in vitro studies of CMV/endothelial cell interaction have been difficult to interpret with respect to clinical observations. Friedman et al. [13] reported a failure to infect endothelial cells (both bovine and human) with the Davis strain of CMV, as determined by the absence of cytopathic changes or CMV nuclear antigens in inoculated cells, as well as by the absence of detectable levels of infectious virus in the corresponding culture supernatants, tto et al. [26] described infection of human endothelial cells with CMV AD 169 and two clinical isolates, as indicated by the development of cytopathic effect (CPE), the expression of CMV antigens, and the production of infectious progeny virus in the inoculated cultures. In that study, enhanced CPE was observed in cells inoculated with the clinical isolates as compared with that observed in AD169-infected cultures. More recently, Smiley et al. [59] reported infection of human umbilical vein endothelial cells with the Towne strain of CMV without accompanying morphologic cytopathology. Although the infection was associated with production of infectious virus, the reproductive efficiency was considerably lower than in similarly inoculated fibroblasts. Indeed both Radsak et al. [45] and Bruggeman et al. I-7] have reported very low infection efficiency in endothelial cells inoculated with Towne strain [45] , AD169, or Kerr strain [7] , even at high input titers (5-10 M.O.I.). Collectively, these findings suggest the specific nature of the CMV/endothelial cell interaction to be both qualitatively and quantitatively dependent upon virus strain and/or in vitro propagation history of the virus.
Traditionally, CMV has been propagated in fibroblasts, as these cells seem to be the most permissive for virus reproduction. Although this has proved an effective means for generating large quantities of virus for study, the recent emergence of the role of the endothelial cell in human CMV infection prompted us to pursue an alternative approach. In an effort to develop an accurate in vitro model of CMV/endothelial cell interaction, we have propagated a CMV isolate through multiple passages in human umbilical vein endothelial cells and, separately, in neonatal human dermal fibroblasts (for comparative purposes). Results of our earlier studies with low passage endothelial-raised CMV indicated significantly enhanced endothelial cytopathic potential, as compared with CMV AD169 [66] , suggesting that continuous propagation in fibroblasts may alter characteristics of the virus. We now extend these findings by reporting dramatic diversification in the cytopathic and reproductive properties of our isolate as a function of the host system in which the virus was serially propagated. We demonstrate that, while the process of fibroblast-adaption restricts the host range of CMV and attenuates its cytopathic potential, endothelial-based propagation produces a progeny that retains the endothelial cytopathogenicity of the original isolate.
Materials and methods

Cell culture
Neonatal human dermal fibroblasts (NHDF), isolated from human foreskins, were propagated in Eagle's MEM modified by the addition of essential and non-essential amino acids and vitamins, and supplemented with 10% fetal bovine serum (Hyclone), Cultures were incubated at 37 °C in a humidified environment of 5% CO2/95% air, and were passed weekly at a ratio of 1:2. Cultures used in experiments were of passage 10-20.
Human umbilical vein endothelial cells (HUVE) were isolated from vessels by a mod-ification [64] of the techniques of Gimbrone et al. [16] and Jaffe et al. [29] . Cultures were propagated in endothelial cell growth medium (ECGM), consisting of M-199 (Gibco) supplemented with 20% fetal bovine serum, 100 gg/ml endothelial celt growth factor (ECGF, prepared according to the methods of Maciag etal. [35] ), 12 U/ml sodium heparin, and 20 mM Hepes buffer. All growing surfaces for HUVE cells were pretreated with fibronectin. Cells were passed weekly at a ratio of 1:2. Cultures of passage 4-8 were used in experiments.
Virus propagation
CMV strain AD169 was obtained from the American Type Culture Collection and propagated in NHDF cells. CMV strain VHL was isolated from a duodenal biopsy of a bone marrow transplant recipient with histologically verified CMV infection of the duodenum. The original diagnostic fibroblast culture (exhibiting extensive CPE) was divided into two aliquots for propagation in endothelial cells (VHL/E) and, separately, in fibroblasts (VHL/F). Endothelial cell-based propagation methods have been described previously [66] . Briefly, the specimen was inoculated onto a confluent low passage HUVE monolayer. Obvious cytopathic changes were visible by day 5 post-inoculation (PI). When > 90% of the cells exhibited CPE the culture was suspended by trypsinization (0.01% trypsin, 0.02% EDTA, t:1) and reinoculated onto fresh HUVE monolayers. In this manner the virus has been propagated through 20 passages in endothelial cells (VHL/E20).
Although the initial inoculation of the clinical diagnostic culture introduced a small number of fibroblasts into the endothelial culture, these cells deteriorated rapidly and, by the second passage of the infected HUVE cells, no evidence for the persistence of fibroblasts was apparent, as determined by both morphologic criteria and staining for von Willebrand factor (see below).
The remaining portion of the specimen was inoculated onto N~tDF cells for traditional fibroblast-based propagation. By serial passage of heavily infected cultures (> 90% CPE) onto fresh N H D F monolayers, this sub-strain has been propagated through 20 passages in fibroblasts (VHL/F20).
Frozen stocks of CMV AD169 and CMV VHL/F were prepared from heavily infected NHDF cultures (> 90% CPE), while stocks of VHL/E were prepared from equivalently cytopathic HUVE cultures, as described previously [66] .
Concentrations of virus stocks, in terms of plaque forming units (PFU)/ml, were determined by plaque assay titration on N H D F monolayers in 6-well culture plates (Corning), according to a protocol based on the method of Wentworth and French [69] . Titers of each viral strain were derived from counts of 10 replicate wells.
Acute injection of endothelial cells and fibroblasts
For acute infection studies, HUVE cells were plated in fibronectin-treated glass chamber slides (Nunc), while NHDF cells were plated in plastic ones. Cultures were grown to confluence, washed twice with phosphate buffered saline (PBS) and inoculated with either CMV AD169, CMV VHL/E, or CMV VHL/F, at titers ranging from 10 -2 to I0 ° PFU/ cell. To verify staining specificity, each experiment included sham-inoculated cultures, as well as cultures inoculated with herpes simplex (HSV 1, strain KOS). Following 1.5h adsorption at 35.5 AD, inocula were removed and cultures were washed twice with PBS before addition of virus-free growth medium supplemented with gentamicin sulfate (100 gg/ ml) and amphotericin B (250 ng/ml). Slide cultures were incubated for various intervals (1-20 days) at 35.5 AD, then washed twice with PBS and fixed in cold acetone (4 °C)c for 10 min for staining. In addition, growing cultures were observed throughout the course of infection for the appearance of cytopathology.
Detection of CMV DATA by in situ hybridization
In situ hybridization was performed according to a protocol based on the methods of Brigati et al. [5] and Unger et al. [63] , as detailed elsewhere [48] . Briefly, fixed culture slides were incubated with biotinylated, CMV-or HSV-specific DNA probes (ENZO Biochem), first at 85 °C for 11 rain to allow denaturation, then at 37 °C for 12 h for hybridization. The bound probe was visualized following 20 rain incubation (37 °C) with horseradish peroxidase-conjugated avidin D (Vector, diluted 1:500 in Tris-buffered saline [TBS: 0.05 M Tris HC1 in 0.85% NaC1, pH 7.6]), by development in 0.024% aminoethylcarbazole.
Demonstration of yon Willebrand factor by immunocytochemistry
In order to verify the endothelial identity of infected cells, a sampling of fixed culture slides was stained for yon Willebrand factor prior to in situ hybridization, by an immuno-atkaline phosphatase assay based on the methods of Mukai et al. [38] , as described previously [48] .
Demonstration of viral antigen expression by immunocytochemistry
As further confirmation of CMV infection, fixed culture slides were stained for CMVspecific antigens by an immunoperoxidase technique based on methods described by Sharma et al. [56] . Primary CMV-specific antibodies, originally developed by Shuster et al. [57] , included mouse monoclonal antibodies directed against (1) CMV early nuclear protein and, (2) CMV late nuclear protein (both from DuPont). Additionally, a pool of 3 mouse monoclonal anti-HSV primary antibodies (Bartel) was used as a specificity control. Primary antibodies were diluted in TBS (1:100 for anti-HSV and anti-CMV early, 1:150 for anti-CMV late).
Briefly, fixed culture slides were incubated 45 rain at 37 °C with primary antibodies, washed, then incubated 15 rain (37 °C) with a secondary antibody preparation consisting of a biotinylated horse anti-mouse IgG (Vector) diluted 1:200 in TBS supplemented with 0.2% gelatin. Bound antibody complexes were visualized following 15rain incubation (37 °C) with peroxidase-labelled avidin D, by development in 0.024% aminoethylcarbazole, as described above.
Viral reproductive activity
Plaque assay of infectious virus production Virus production by infected cells was quantified by plaque assay of culture supernatants and, separately, of cell harvests (cell fraction), at various intervals over the course of infection. HUVE cells were grown to confluence in fibronectin-treated 25 cm 2 plastic culture flasks and inoculated with either a virus-free preparation (sham inoculum), CMV AD 169, CMV VHL/E, or CMV VHL/F, at a titer of 10 -~ PFU/cell. Following 1.5 h adsorption, cultures were washed three times with PBS and once with serum-free medium. Complete medium, supplemented with gentamicin and amphotericin B, was added (5 ml/flask), and flasks were incubated at 35.5 °C as described above. The final rinse was reserved for a baseline (day 0) supernatant plaque assay. In additon, the correponding monolayer was harvested for cell fraction plaque assay as described below. Confluent N H D F cultures were inoculated in an identical manner for comparative purposes.
At various intervals throughout the course of infection (30-35 days) cultures were harvested for assay as follows. Supernatant was withdrawn and reserved for plaque assay. The corresponding monolayer was washed twice with PBS, released from the substrate by addition of0.01% trypsin (0.25 ml) and 0.02% EDTA (0.25 ml), then resuspended in storage medium (40% MEM, 10% fetal bovine serum, 50% sucrose phosphate buffer [18mM sucrose, 12raM K2HPO4, 7.5raM KHzPO4] ). This celt fraction was then prepared for plaque assay by the rapid freeze-thaw method. Remaining unharvested cultures were supplied with fresh growth medium.
Plaque assays of supernatants and cell fractions were performed by a modification of the methods of Wentworth and French, as described previously [69] .
Determination of viral DNA polymerase activity
As an additional determination of viral reproductive activity, CMV-specific DNA polymerase assays were performed on infected cell cultures at various intervals following inoculation. HUVE and N H D F cells were grown to confluence in 75 cm 2 plastic tissue culture flasks (Coming) and inoculated with either CMV AD169, CMV VHL/E, CMV VHL/F (10 -; PFU/cell), or a sham perparation, according to the protocol described above. At various post-inoculation intervals (corresponding to those selected for plaque assay), replicate infected cell fractions were harvested for polymerase assay as follows. Supernatant was removed and cells were washed twice with PBS, then released from the substrate by trypsinization (0.01% trypsin, 0.02% EDTA, 1 ml each/flask). Cells were suspended in 10ml complete MEM, then centrifuged at 500 x g for 10 rain. Following aspiration of the supernatant, pellets were washed in PBS then resedimented by centrifugation. The supernatant was again aspirated and pellets were cryopreserved at -8 0 °C until assayed.
CMV-specific DNA potymerase assay protocol was based on previously established technqiues [27, 30, 53, 61] . Frozen cell pellets were thawed, suspended in 0.5 ml extraction buffer (50 mM Tris-HCl [pH 7.5], 3 mM dithiothreitol, 200 mM KC1, 2 mM ATP-Mg), and disrupted by sonication (Branson Sonifier, output setting of 6, duty cycle 40%, 15 pulses/ sample). The resulting homogenates were clarified by 2 rain centrifugation (Fisher Model 235 A microfuge). Each DNA polymerase reaction mixture contained in a total volume of 0.t ml:50 mM Tris-HC1 (pH 8.0), 150 mM KC1, 4raM MgCI2, 8 gg bovine serum albumin, 1 mM dithiothreitol, 2.25% (v/v) glycerol, 100gM each of dATP, dCTP, dGTP, 1.6~tM [3H]dTTP (500gCi/gmol), 13 gg of activated calf thymus DNA, and 10gl cell lysate [30, 61] . Assays were incubated at 37 °C in a shaking water bath for times ranging from 15 rain to 2 h (depending on inherent activities of the samples). Reactions were terminated after spotting on Whatman 3 MM discs, by two 5 min washes in cold 5% TCA/1% sodium pyrophosphate [53] . Discs were dried following a final ethanol wash, immersed in toluene scintillation cocktail and counted in a Beckman LS 8100 counter.
Each sample was assayed at least in triplicate, and each series included 0-time reaction controls, sham-inoculated negative controls, high activity positive controls, and unwashed discs as indicators of total available label activity. Polymerase activity was expressed as nmol [3H]dTTP incorporated into acid-insoluble material/ml/h.
Direct visualization of viral partictes by electron microscopy
As final confirmation of viral activity, intracellular Herpes-type virions were directly visualized by transmission electron microscopy. HUVE and NHDF cultures were grown to confluence in 75 cm 2 culture flasks and inoculated, as described previously, with ADI69, VHL/F20, VHL/E20 (10-2 PFU/cell), or a sham preparation. Cultures were incubated until cytopathic changes were widespread, then harvested and fixed as described below. AD 169-or VHL/F-inocutated HUVE cultures, in which obvious cytopathic effect was never observed, were incubated 7 days.
To prepare for processing, cells were harvested by addition of trypsin/EDTA, suspended in growth medium, then pelleted by centrifugation (400 x g, 5 rain). Cells were washed twice in PBS, then fixed by the additon of 1 mt 2% phosphate buffered gtuteraldehyde and again pelleted by centrifugation.
To prepare for embedding, specimens were post-fixed in 1% phosphate buffered osmium tetroxide (1 h), then dehydrated in graded ethanol washes. Specimens were embedded in Spurr low viscosity embedding media (SEM). Blocks were cured for a minimum of 12 h at 70 °C.
Thin sections (approximately 100 nm) were cut from cured blocks using an ultramicrotome (LKB Nova), and mounted on 2ram 200 mesh copper grids. Grids were heavy metal-stained using a standard two-step uranyl acetate/lead citrate technique, then examined and photographed with a Hitachi HU-12 transmission electron microscope.
Results
Morphologic cytopathology in CMV-infected endothelial cells
We have previously described cytopathic changes induced in HUVE cells by CMV VHL/E upon initial isolation of the virus and at early passage [66] . We now report identical cytopathology in endothelial cell cultures inoculated with this strain following 20 passages in HUVE. Lesions in the monolayer initiated within 3 days PI as small regions of apparent cell fusion, followed by increasing refractility and rounding of the multicellular mass, as well as by the appearance of satellite lesions about the initial cytopathic focus. Advancing cytopathology progressed to ultimately involve the entire monolayer (Fig. 1 A) .
In contrast, the endothelial cytopathic potential of VHL/F was lost after 20 passages in fibroblasts. No obvious cytopathology was observed in endothelial cells infected with this sub-strain at any time throughout the course of infection up to 35 days PI (Fig. 1 B, C) . Cells in which infection was verified both by the presence of CMV DNA and by the expression of CMV-specific antigens appeared unperturbed at the light microscope level. Similarly, AD 169-infected HUVE cells were morphologically indistinguishable from sham-inoculated controls (data not shown, see [66] ).
Infection of N H D F cells with CMV VHL/E or VHL/F resulted in typical CMV/fibroblast cytopathology qualitatively similar to that induced by AD 169 and other strains of CMV.
Demonstration of CMV DNA in injected endothelial cells"
In order to identify infected cells, and to confirm the identity of the virus, slide cultures were stained for CMV DNA by in situ hybridization. Sham-inoculated, and HSV 1-infected cultures were included in these experiments as specificity controls for the DNA probes.
Results of hybridization studies with VHL/E20 confirmed our previous identification of this virus as a CMV strain. Cytopathic changes were again evident in endothelial cells staining positively for viral DNA (Fig. 2) . In contrast, the response of HUVE cultures to VHL/F20 inoculation closely resembled that observed with AD169 infection (data not shown; see [66] ); CMV DNA-positive cells occurred with low frequency and without accompanying cytopathology.
To confirm the endothelial identity of the infected cells, a sample of culture slides was immunohistochenaically stained for von Willebrand factor (vWF) prior to in situ hybridization. The demonstration of vWF expression in CMV DNA-positive cells thus verified their endothelial lineage (data not shown; see [48, 66] ). Attempts to hybridize HSV probes with CMV-infected cultures, or CMV probes with HSV-infected cultures all yielded negative results (data not shown), verifying the specificity of the probes, and ruling out the possibility of contamination of the CMV strains with HSV. Additionally, sham-inoculated cultures showed no evidence of hybridization with either probe.
Finally, we note that fibroblast cultures inoculated with each of the CMV strains exhibited positive hybridization staining within cytopathic loci (data not shown). As expected, attempts to detect vWF expression in these cells consistenly yielded negative results.
Demonstration of CMV-specific antigen expression in infected endothelial cells
As further confirmation of CMV infection in inoculated HUVE cultures, slides were stained for either CMV early nuclear protein or CMV late nuclear protein using primary antibodies directed against each of these antigens [52] . Shaminoculated, and HSV-infected cultures were included in these experiments as specificity controls for the antibody reactions.
Results of immunohistochemical staining were consistent with those of the hybridization studies described above. While VHL/E-infected HUVE cells (as determined by positive staining for both CMV early and late nuclear proteins) exhibited obvious cytopathic changes (Fig. 3) , VHL/F-and AD169-infected cells were few, and appeared morphologically unperturbed (data not shown; Staining of fibroblast cultures inoculated with each CMV strain also yielded results consistent with hybridization studies. Cells within or peripheral to cytopathic foci exhibited positive staining for both early and late antigens (data not shown).
Quantitation of viral reproductive activity
Infectious virus production
Earlier studies of the characteristics of VHL/E (at passage 6) indicated that this virus reproduced more efficiently in endothelial cells than in fibroblasts [661. This conclusion, however, was based on plaque assay of only the supernatant fraction of infected cultures. Visual observation of the progression of cytopathic changes in inoculated HUVE cultures suggested that data derived exclusively from supernatants may have underestimated the true extent of viral reproductive activity. Therefore, in this series of experiments, we have quantified the plaque forming potential of supernatants and, separately, of cell fractions from cultures inoculated with either VHL/E20 or VHL/F20, at various intervals PI.
Results of these studies demonstrate dramatic differences between the reproductive activities of VHL/E20 and VHL/F20. Whereas VHL/E has retained the ability to initiate sustained productive infection in endothelial cells, this potential has been severly attenuated in VHL/F following 20 passages in fi- Fig. 4A) . Conversely, the efficiency of VHL/F20 replication in fibroblast culture can be seen to exceed that of VHL/E20 by several orders of magnitude (Fig. 4 B) . Comparing the virus production curves generated by each individual sub-strain in the two cell types (Fig. 5 A, B) with the curves generated in our earlier experiments with supernatants from AD 169-infected cultures (Fig.  6) , it is clear that VHL/F has come to resemble AD169 in its host preference. Another distinction that has developed between the two VHL variants relates to the extent of release of free virions into the supernatant. In VHL/E-infected HUVE cultures, the greater plaque forming potential was found in the cell fraction as compared to that found in the supernatant (Fig. 7 A) . Such was also the case in VHL/E-infected N H D F cultures (data not shown), suggesting retention of the tendency of newly isolated CMV to remain cell-associated [50, 68] . This likely accounts for our previous underestimation of virus production when only supernatants were assayed [66] . In contrast, VHL/F-infected cells released a greater quantity of infectious virus into the supernatant than was retained in the cell fraction (Fig. 7 B) . Again we observed progressive advance of dramatic cytopathology within VHL/E-infected HUVE monolayers, while no obvious changes occurred in In an effort to strengthen the arguments set forth in the previous section, and to circumvent the requirement of assaying endothelial-propagated virus in a fibroblast-based plaque assay system, viral reproductive activity was quantified on the biochemical level by determination of CMV-specific DNA polymerase activity in lysates of infected cells. Cultures of N H D F and HUVE cells were inoculated with each of the virus strains, then harvested for assay at postinoculation intervals corresponding to those chosen for plaque assay. Data generated by polymerase assay of these harvests were plotted as [3H]-TTP incorporation (into activated DNA template) vs. time PI, and superimposed on plaque assay data. Two representative examples of these results are shown in Fig. 7 A and B. These graphs clearly show that trends in potymerase activity, as a function of time PI, closely parallel those of infectious virus production.
In all experiments, polymerase activity was consistent with plaque forming potential. Correlation coefficients for each series, derived from first order regression plots of polymerase activity vs. plaque forming potential, are listed in Table 1 .
Electron microscopy of intracellular viral particles
Representative examples of transmission electron micrographs are presented in Fig. 8 . Characteristic Herpes-type capsids were abundant in nuclei of HUVE (Fig. 8 A) , as well as in nuclei of N H D F cells inoculated with either of the three viral strains. In addition, complete enveloped virions were visible in the cytoplasm (Fig. 8 B) . In contrast, an exhaustive search for viral particles within HUVE cells inoculated with AD 169 or VHL/F~0 proved unsuccessful.
Discussion
Endothelial involvement in human CMV disease has been well documented. Studies of tissue sections obtained by biopsy and at autopsy have shown evidence of CMV infection in endothelial cells within most organ systems, including lung [9] , skin [34] , retina [1] , and gastrointestinal tract [12, 18, 19, 25, 60] , as well as spleen and pancreas [39] , and peritoneum [65] . Most often, infected cells have exhibited classical CMV-associated morphologic derangements (cytomegaly, nuclear and cytoplasmic inclusions). However, results of in vitro studies of CMV/endothelial cell interactions have frequently been difficult to resolve with clinical observations. While Friedman et al. [13] were unable to demon- [7, 45] . It has also been somewhat perplexing that productive infection by laboratory-adapted strains has been demonstrated in the absence of obvious morphological cytopathic change. Previous results from our laboratory [48, 66] have also shown production of infectious virus by endothelial cells morphologically indistinguishable from sham-inoculated controls.
In an effort to develop an accurate in vitro model of CMV/endothelial cell interaction, we have sought to clarify these apparent discrepancies by propagating a single clinical isolate through multiple passages in human umbilical vein endothelial cells and, separately in neonatal human dermal fibroblasts. In our earlier comparison of the infectious properties of AD169 with those of the endothelial-raised strain (previously referred to as VHL 1), productive infection in HUVE cells (by VHL 1) was accompanied by dramatic cytopathology not observed in AD 169-inoculated cultures [66] . In addition, quantitative, strainspecific differences in reproductive potential were noted. As CMV AD169, isolated in 1956 [50] , has been extensively propagated in fibroblasts, the above results suggest that the process of fibroblast-adaption may significantly diminish the natural ability of this virus to interact with endothelial cells. However, since AD169 and VHL are of separate origins, it could be legitimately argued that their different behaviors in vitro are inherently strain-related, rather than a result of their modes of propagation.
To resolve this issue and to determine whether the endothelial cytopathogenicity of freshly isolated CMV can be preserved in culture, we have directly compared the infectious properties of our isolate following 20 passages in endothelial cells (VHL/E20) with those of the same isolate propagated through 20 passages in fibroblasts (VHL/F20). Results of these experiments clearly show that dramatic diversification has occurred as a function of host system. While VHL/E has retained its endothelial cytopathic potential, this property was lost after 20 passages in fibroblasts. Additionally, the efficiency of acute endothelial cell infection by VHL/F, as indicated by the frequency of positive staining for CMV antigens or DNA, has been significantly attenuated. Similarly, the ability of VHL/F to initiate sustained productive infection in HUVE cultures has been nearly lost. Plaque assay of culture supernatants and cell fractions, as well as virus-specific polymerase assay of cell lysates, have demonstrated progressive viral reproductive activity in VHL/E-inoculated HUVE cultures, whereas VHL/ F production was barely detectable.
Results of electron microscopy studies also reflected this pattern. The abundance of viral particles observed within endothelial cells inoculated with VHL/ E20 has confirmed, by direct visualization, the infectivity and reproductive potential of this strain in HUVE culture. Conversely, the inability to locate even a single intracellular virion following inoculation of endothelial cells with either AD 169 or VHL/F20 reinforces the above observations of negligible viral activity induced by these strains in HUVE cultures.
Yet another distinction that has developed between the two sub-strains relates to the relative distribution of viral progeny between the supernatant and cell fractions in actively productive cultures. Whereas newly replicated VHL/ E remains primarily cell associated (a characteristic of freshly isolated CMV), the majority of plaque-forming activity of VHL/F is found in the supernatant. In particular, the data generated by virus production studies in inoculated NHDF cells clearly indicate that VHL/F has undergone the classical fibroblastadaption process [50, 68] . Replication of this sub-strain in NHDF proceeds rapidly and efficiently, with abundant progeny being shed into the culture medium. In all of these respects, VHL/F has come to resemble AD 169 and other laboratory-adapted CMV strains. In contrast, it must be emphasized that no modifications in the properties of VHL/E were observed throughout its culture history. Cytopathology induced in both endothelial cells and fibroblasts by VHL/E20 was identical to that observed upon initial isolation, and replication kinetics of this sub-strain were similar at all passages studied.
The idea of alteration of infectious properties in viruses as a result of extensive in vitro propagation is by no means new. With regard to CMV, this concept was alluded to as early as 1970 by Weller [671, and has been the basis of an approach to developement of anti-CMV vaccination employing the Towne strain [44] . Indeed, Ho et al. [26] observed that recent clinical isolates of CMV showed more extensive cytopathic effect in endothelial cells than did AD169. Einhorn and Ost [10] found that low passage CMV isolates regularly induced CMV early antigens in human leukocytes, while antigen-positive cells were rare in AD169-inoculated suspensions. Whereas early attempts to infect cultured human nasopharyngeal epithelium with Epstein-Barr virus released from established productively infected lymphoid cell lines failed [17, 55] , Sixbey et al. [58] succeeded using wild type virus from fresh oropharyngeal washings. Similarly, Carpenter and Chesebro [81 reported a dramatic shift in cell tropism of equine infectious anemia virus following repeated passage in equine dermal cell cultures. Infectivity for horse macrophages (the natural host cell in vivo) continually declined, while viral tropism for dermal cells was progressively augmented.
Regarding mechanisms responsible for the modifications in viral characteristics reported here and observed by others, several possibilities are worthy of consideration. Alterations in viral DNA has been demonstrated by both Furukawa E15] and Ogura et al. [41] when CMV variants were recovered from persistently infected cells 9-12 months after inoculation with Towne strain. In both cases these variants showed structural alterations in their genomes, as demonstrated by restriction fragment analysis, when compared with the original inocula. A similar approach to distinguishing our two sub-strains might prove fruitful; however, due to the relative enormity and complexity of the CMV genome, as well as its tendency to isomerize, a search for subtle polymorphisms W.J. Waldrnan et al. may be exhaustive. Alternatively, modification of the viral proteins may account for the changes in infectivity. Since CMV obtains its envelope from virally modified host cell membrane components, a host-related alteration in protein profile would not be unexpected, and might explain the observed apparent shift in cell affinity. Resolution of these issues will require further detailed investigation. Nevertheless, it is clear that the host-specific intracellular environment profoundly influences the properties of the resulting progeny virus.
A common objective of in vitro research in viral pathogenesis (indeed, of nearly all in vitro experimentation) is the accurate modeling of processes which occur in vivo. In order to provide sufficient material for study, clinical viral specimens must be propagated within a suitable host culture system. This requires not only that the host cell be permissive for viral replication, but also that the characteristics of the resulting viral progeny closely resemble those of the original isolate. Our studies have shown that, although fibroblast-based propagation of CMV satisfies the first (quantitative) criterion, the properties of the virus thus generated, at least with regard to endothelial cell interactions, are dramatically altered. The restricted host range of fibroblast-adapted CMV, as well as its attenuated spectrum of cytopathic potential, may compromise its utility as an in vitro model. As an alternative approach, we have demonstrated that endothelial-based propagation of this virus provides the necessary quantities of progeny while preserving the natural endothelial cytopathogenicity of the original isolate. Considering the accumulating evidence for a central role of the endothelial cell in disseminated CMV disease, we propose that a strain of the virus propagated in endothelial cells can provide a more accurate in vitro model of this important aspect of human CMV infection.
